SCUBA

CD22 — CD22 molecule

CD22 belongs to a gene co-expression module in 2 of 28 SCUBA cell types. Each module groups genes that rise and fall together in that cell type; the genes it shares a module with are its closest co-expression partners there.

CD22's module in each cell type

Cell typeModuleShares the module with
CD19⁺ B cellsBCR signaling/maturation
B cell maturation
ATP6V0A1, BCL11A, CAMK2D, CLEC2D, DDHD1, DGKD, IL4R, ITPR1 +9 moreView in SCUBA
Hematopoietic progenitor cellsLymphoid-Primed Progenitor
Lymphcyte development
ARHGAP27, COBLL1, LILRB2, LTB, PACSIN1, S100Z, SH3TC1, SLC2A5 +4 more

About the gene

SynonymsSIGLEC-2, SIGLEC2
Chromosome19: 35319261-35347361
Predicted locationIntracellular, Membrane
Essential geneNo
Protein classCD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins
Biological processCell adhesion

Function

Most highly expressed siglec (sialic acid-binding immunoglobulin-like lectin) on B-cells that plays a role in various aspects of B-cell biology including differentiation, antigen presentation, and trafficking to bone marrow. Binds to alpha 2,6-linked sialic acid residues of surface molecules such as CD22 itself, CD45 and IgM in a cis configuration. Can also bind to ligands on other cells as an adhesion molecule in a trans configuration. Acts as an inhibitory coreceptor on the surface of B-cells and inhibits B-cell receptor induced signaling, characterized by inhibition of the calcium mobilization and cellular activation. Mechanistically, the immunoreceptor tyrosine-based inhibitory motif domain is phosphorylated by the Src kinase LYN, which in turn leads to the recruitment of the protein tyrosine phosphatase 1/PTPN6, leading to the negative regulation of BCR signaling. If this negative signaling from is of sufficient strength, apoptosis of the B-cell can be induced.

Human Protein Atlas · Open Targets · UniProt

Gene annotation from the Human Protein Atlas and UniProt; see sources & licences.